George Harrison Talbot, Director at Nabriva Therapeutics AG (NBRV), sold 210 shares at $101.00 ($21K) on 2017-05-30, disclosed to the SEC on 2017-06-01.
Open-market sale of $21k NBRV by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $101.00 | 100 | $10K | 47.5% |
| 2 | $101.50 | 110 | $11K | 52.5% |
| Total | $101.26 avg | 210 | $21K | 100% |
| Filing → |
| NBRV | SELL | 2017-05-25 | $33K | — | Filing → |
| NBRV | SELL | 2017-05-17 | $21K | — | Filing → |